Top Markets
Coin of the day
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
株式のランク #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
株価
$29.06
最終同期: 2023-02-23
時価総額
$682.73M
変化(1日)
-0.48%
変化(1年)
0.00%
US
取引 CinCor Pharma, Inc. (CINC)

カテゴリー

CinCor Pharma, Inc.(CINC)の株価履歴
終値の最高値: $29.26 (2023-02-01)

終値の最安値: $16.50 (2022-01-01)
CinCor Pharma, Inc. の株価履歴(2022 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 146.11%
2022 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH